Covid vaccines are once again on the agenda for the Centers for Disease Control and Prevention’s vaccine advisory panel.

Moderna has announced that the FDA will initiate the review of its seasonal influenza vaccine candidate, mRNA-1010.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...

By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it ...

Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline ...

In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.

In 1991, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended hepatitis B vaccination at birth for all ...

Pfizer’s Albert Bourla put it more bluntly in Davos last month, saying it’s a “different world when you start discussing ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsAndrew Guggenhime - President & CFOGrant Pickering ...